Latest News

Featured image for “Greenfern eyes FDA-approved cannabinoid medicine opportunity as part of multi deal”

Greenfern eyes FDA-approved cannabinoid medicine opportunity as part of multi deal

Patients in New Zealand, Australia and the Pacific Islands could soon have access to Syndros, one of only four Food and ...

Featured image for “Cannasouth Cultivation Facility Achieves GACP Certification”

Cannasouth Cultivation Facility Achieves GACP Certification

Cannasouth Limited (NZX:CBD) is pleased to announce that its subsidiary, Cannasouth Cultivation Limited, has today received it’s Good Agricultural and Collection ...

Featured image for “Greenfern remains NZ’s only Toitū net carbonzero medicinal cannabis company, recertified again”

Greenfern remains NZ’s only Toitū net carbonzero medicinal cannabis company, recertified again

Greenfern Industries continues to lead the way both locally and internationally, having been certified a Toitū net carbonzero organisation for the ...

Featured image for “Cannabinoids could provide relief from neuropathic pain”

Cannabinoids could provide relief from neuropathic pain

A three-year neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating ...